证券代码：839729 证券简称：永顺生物 公告编号：2025-052 广东永顺生物制药股份有限公司 年度报告重大差错责任追究制度 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 审议及表决情况 公司于 2025 年 8 月 25 日召开第五届董事会第十一次会议，审议通过《关 于制定及修订公司部分内部管理制度的议案（无需股东会审议）》之子议案 2.09： 修订《年度报告重大差错责任追究制度》。议案表决结果：同意 6 票；反对 0 票； 弃权 0 票。本子议案无需提交股东会审议。 二、 分章节列示制度主要内容： 第一条 为进一步提高广东永顺生物制药股份有限公司(以下简称"公司") 规范运作水平，增强信息披露的真实性、准确性、完整性和及时性，提高年报信 息披露的质量和透明度，根据《中华人民共和国公司法》（以下简称"《公司法》"）、 《中华人民共和国证券法》（以下简称"《证券法》"）、《中华人民共和国会计法》 （以下简称"《会计法》"）、《北京证券交易所上市公司持续监管办法（试行）》、 《北京证券交易所 ...

证券代码：839729 证券简称：永顺生物 公告编号：2025-064 广东永顺生物制药股份有限公司 对外担保管理制度 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 审议及表决情况 公司于 2025 年 8 月 25 日召开第五届董事会第十一次会议，审议通过《关 于制定及修订公司部分内部管理制度的议案（尚需股东会审议）》之子议案 3.04： 修订《对外担保管理制度》。议案表决结果：同意 6 票；反对 0 票；弃权 0 票。 本子议案尚需提交股东会审议。 二、 分章节列示制度主要内容： 广东永顺生物制药股份有限公司 对外担保管理制度 第一章 总则 第一条 为依法规范广东永顺生物制药股份有限公司（以下简称"公司"） 的对外担保行为，有效控制公司的对外担保的风险，保护公司资产安全，促进公 司健康稳定发展，根据《中华人民共和国民法典》、《中华人民共和国公司法》（以 下简称"《公司法》"）《中华人民共和国证券法》等相关法律、法规、规范性文件 以及《北京证券交易所股票上市规则》和《广东永顺生物制药股份有限公 ...

证券代码：839729 证券简称：永顺生物 公告编号：2025-076 广东永顺生物制药股份有限公司 防范控股股东、实际控制人及关联方资金占用管理制度 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 审议及表决情况 公司于 2025 年 8 月 25 日召开第五届董事会第十一次会议，审议通过《关 于制定及修订公司部分内部管理制度的议案（尚需股东会审议）》之子议案 3.16： 制定《防范控股股东、实际控制人及关联方资金占用管理制度》。议案表决结果： 同意 6 票；反对 0 票；弃权 0 票。本子议案尚需提交股东会审议。 二、 分章节列示制度主要内容： 度。 第二条 公司及纳入公司合并会计报表范围的子公司与公司控股股东、实际 控制人及其他关联方之间的资金往来适用本制度。 第三条 公司董事和高级管理人员对维护资金安全负有法定义务。 广东永顺生物制药股份有限公司 防范控股股东、实际控制人及关联方资金占用管理制度 第一章 总则 第一条 为规范广东永顺生物制药股份有限公司（以下简称"公司"）与控 股股东、实际 ...

广东永顺生物制药股份有限公司独立董事工作制度 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、 审议及表决情况 公司于 2025 年 8 月 25 日召开第五届董事会第十一次会议，审议通过《关 于制定及修订公司部分内部管理制度的议案（尚需股东会审议）》之子议案 3.03： 修订《独立董事工作制度》。议案表决结果：同意 6 票；反对 0 票；弃权 0 票。 本子议案尚需提交股东会审议。 证券代码：839729 证券简称：永顺生物 公告编号：2025-063 主要股东、实际控制人不存在直接或间接利害关系，或者可能影响其进行独立客 观判断关系的董事。 独立董事应当独立履行职责，不受公司及其主要股东、实际控制人等单位 或个人的影响。 独立董事对公司及全体股东负有忠实与勤勉义务，应当按照法律、行政法 规、中国证券监督管理委员会（以下简称"中国证监会"）规定、北京证券交易 所（以下简称"北交所"）业务规则和《公司章程》的规定，认真履行职责，在 董事会中发挥参与决策、监督制衡、专业咨询作用，维护公司整体利益，保护 ...

Market Trends - The online sales proportion of small home appliances in China increased from 68% in 2020 to 79% in 2024, while offline retail sales of kitchen appliances are expected to decline by 9.1% year-on-year in 2024[2] - The small home appliance market in China is projected to reach a scale of 539.2 billion yuan by 2027[20] - In the first five months of 2025, the sales revenue of small home appliances reached 61.5 billion yuan, with a growth rate of 16.1%[24] Policy Impact - The "old for new" policy in the appliance sector has expanded to include 12 categories, stimulating market recovery and showing significant consumer potential[24] - In 2025, the total sales of the home appliance market reached 402.2 billion yuan, reflecting a year-on-year growth of 12.7%[24] Stock Performance - The median stock price change for consumer service stocks on the Beijing Stock Exchange was +4.34% from August 18 to August 22, 2025, with 95% of companies experiencing an increase[42] - The total market capitalization of consumer service companies rose from 118.94 billion yuan to 126.47 billion yuan during the same period[45] Valuation Metrics - The median price-to-earnings (P/E) ratio for consumer service companies increased from 50.4X to 52.3X[44] - The median P/E ratio for the broader consumer sector rose by 10.32% to 79.7X[51]

Market Overview - On August 22, the total trading volume of individual stocks on the Beijing Stock Exchange reached 1.243 billion shares, with a total transaction value of 32.641 billion yuan, a decrease of 4.936 billion yuan compared to the previous trading day [1] - Among the tradable stocks, 83 stocks closed higher, accounting for 30.40% of the total, with notable gainers including Nengzhiguang, Tonghui Electronics, and Haidaer, which rose by 344.38%, 15.87%, and 14.82% respectively [1][2] - Conversely, 186 stocks closed lower, with the largest declines seen in Zhuozhao Diangao, Hongyuan Co., and Yongshun Biological, which fell by 4.71%, 4.50%, and 4.36% respectively [1] Stock Performance - Nengzhiguang (920056) debuted with a remarkable increase of 344.38%, achieving a turnover rate of 73.08% and a transaction value of 75.78551 million yuan [2] - A total of 103 stocks had transaction values exceeding 10 million yuan, with the top performers being Binhang Technology, Shuguang Digital Innovation, and Nengzhiguang, with transaction values of 1.282 billion yuan, 1.102 billion yuan, and 757.8551 million yuan respectively [2] - The trading activity showed that 41 stocks had a turnover rate exceeding 10%, with 6 stocks exceeding 20% [2] Notable Stocks - The trading details for notable stocks include: - Binhang Technology (839493): Closing price of 189.80 yuan, up 4.57%, turnover rate of 16.17%, transaction value of 1.282 billion yuan [2] - Shuguang Digital Innovation (872808): Closing price of 97.41 yuan, up 5.09%, turnover rate of 5.79%, transaction value of 1.102 billion yuan [2] - Nengzhiguang (920056): Closing price of 32.04 yuan, up 344.38%, turnover rate of 73.08%, transaction value of 757.8551 million yuan [2] - Tonghui Electronics (833509): Closing price of 31.98 yuan, up 15.87%, turnover rate of 19.61%, transaction value of 52.40595 million yuan [2]

Market Overview - The animal health sector experienced a decline of 0.76% on August 22, with Yongshun Biological leading the drop [1] - The Shanghai Composite Index closed at 3825.76, up 1.45%, while the Shenzhen Component Index closed at 12166.06, up 2.07% [1] Individual Stock Performance - Yongshun Biological (code: 839729) closed at 11.18, down 4.36% with a trading volume of 91,600 shares and a turnover of 102 million yuan [1] - Dayu Biological (code: 871970) closed at 10.13, down 2.78% with a trading volume of 32,700 shares and a turnover of 33.49 million yuan [1] - Shunlian Biological (code: 688098) closed at 12.74, down 2.00% with a trading volume of 317,600 shares and a turnover of 412 million yuan [1] - Other notable declines include Xianfeng Holdings (code: 002141) down 1.79% and Jinhai Biological (code: 002688) down 1.36% [1] Capital Flow Analysis - The animal health sector saw a net outflow of 74.19 million yuan from institutional investors, while retail investors had a net inflow of 91.60 million yuan [1] - Key stocks with significant capital flow include: - Huisheng Biological (code: 300871) with a net outflow of 9.62 million yuan from institutional investors [2] - Kexin Biological (code: 688526) with a net inflow of 7.28 million yuan from institutional investors [2] - ST Lvkang (code: 002868) had a net outflow of 3.99 million yuan from institutional investors but a net inflow of 3.77 million yuan from retail investors [2]

证券之星消息，8月20日动物保健板块较上一交易日上涨0.27%，贤丰控股领涨。当日上证指数报收于 3766.21，上涨1.04%。深证成指报收于11926.74，上涨0.89%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | | --- | --- | --- | --- | --- | --- | --- | | 002141 | 后丰控股 | 4.66 | 9.91% | 128.85万 | | 5.73亿 | | 688526 | 科前生物 | 17.75 | 1.02% | 3.69万 | | 6491.03万 | | 838275 | 驱动力 | 10.24 | 0.69% | 2.68万 | | 2725.11万 | | 603566 | 普莱柯 | 15.30 | 0.39% | 5.28万 | | 8055.89万 | | 600195 | 中牧股份 | 7.70 | 0.39% | 10.24万 | | 7851.28万 | | 871970 | 大禹生物 | 10.27 | 0.39% | 3.79万 | | 3888. ...

证券之星消息，8月18日动物保健板块较上一交易日上涨2.2%，申联生物领涨。当日上证指数报收于 3728.03，上涨0.85%。深证成指报收于11835.57，上涨1.73%。动物保健板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 688098 | 申联生物 | 12.83 | 20.02% | 13.27万 | 1.69 Z | | 300871 | 回盛生物 | 24.26 | 7.87% | 30.00万 | 7.20亿 | | 838275 | 驱动力 | 10.02 | 6.60% | 4.35万 | 4273.62万 | | 002141 | 贤丰控股 | 3.91 | 4.27% | 1 85.59万 | 3.38亿 | | 839729 | 永顺生物 | 9.95 | 3.65% | 3.11万 | 3066.40万 | | 871970 | 大禹生物 | 9.98 | 3.42% | 2.96万 | 2928.24万 | | 300119 | 瑞普生物 | ...

Core Insights - The animal health sector experienced a significant increase of 3.86% on August 15, with Shenlian Biological leading the gains [1] - The Shanghai Composite Index closed at 3696.77, up 0.83%, while the Shenzhen Component Index closed at 11634.67, up 1.6% [1] Stock Performance - Shenlian Biological (688088) saw a closing price of 10.69, with a remarkable increase of 19.98% and a trading volume of 435,300 shares, amounting to a transaction value of 441 million yuan [1] - Other notable performers included: - Biological Shares (600201) with a closing price of 8.93, up 6.06% [1] - Ruipu Biological (300119) with a closing price of 22.78, up 5.56% [1] - KQ Biological (688526) with a closing price of 17.24, up 2.44% [1] Capital Flow - The animal health sector saw a net inflow of 49.48 million yuan from institutional investors, while retail investors contributed a net inflow of 40.08 million yuan [1] - Notably, retail funds experienced a net outflow of 89.56 million yuan [1] Detailed Capital Flow Analysis - Shenlian Biological had a net inflow of 54.78 million yuan from institutional investors, while it faced a net outflow of 41.10 million yuan from speculative funds [2] - Biological Shares had a net inflow of 14.26 million yuan from institutional investors, with a net outflow of 33.08 million yuan from speculative funds [2] - Ruipu Biological recorded a net inflow of 1.78 million yuan from institutional investors, while speculative funds saw a net outflow of 16.93 million yuan [2]